| Jul'19 | Jul'18 | Jul'17 | Jul'16 | |||
|---|---|---|---|---|---|---|
Revenue | ||||||
302,836 | 190,174 | 125,717 | 80,325 | |||
Cost of revenue | ||||||
59,669 | 37,875 | 27,472 | 20,127 | |||
Gross profit | ||||||
243,167 | 152,299 | 98,245 | 60,198 | |||
Operating expenses: | ||||||
Sales and marketing | ||||||
169,913 | 116,409 | 79,236 | 56,702 | |||
Research and development | ||||||
61,969 | 39,379 | 33,561 | 20,940 | |||
General and administrative | ||||||
46,598 | 31,135 | 20,521 | 9,399 | |||
Total operating expenses | ||||||
278,480 | 186,923 | 133,318 | 87,041 | |||
Loss from operations | ||||||
-35,313 | -34,624 | -35,073 | -26,843 | |||
Interest income | ||||||
7,730 | 2,236 | 597 | 289 | |||
Other income (expense), net | ||||||
-329 | 79 | -107 | -416 | |||
Loss before income taxes | ||||||
-27,912 | -32,309 | -34,583 | -26,970 | |||
Provision for income taxes | ||||||
743 | 1,337 | 877 | 468 | |||
Net loss | ||||||
-28,655 | -33,646 | -35,460 | -27,438 | |||
Accretion of Series C and D redeemable convertible preferred stock | ||||||
0 | 6,332 | 9,570 | 8,648 | |||
Net loss attributable to common stockholders | ||||||
-28,655 | -39,978 | -45,030 | -36,086 | |||
Net loss per share, basic and diluted (in dollars per share) | ||||||
-0.23 | -0.63 | -1.54 | -1.36 | |||
Weighted-average shares used in computing net loss per share, basic and diluted (in shares) | ||||||
123,566 | 63,881 | 29,221 | 26,521 | |||